• 1
    Besarab A, Coyne DW: Iron supplementation to treat anemia in patients with chronic kidney disease. Nat Rev Nephrol 6:699710, 2010
  • 2
    Atkinson MA, Pierce CB, Fadrowski JJ, Benador NM, White CT, Turman MA, Pan CG, Abraham AG, Warady BA, Furth SL: Association between common iron store markers and hemoglobin in children with chronic kidney disease. Pediatr Nephrol 27:22752283, 2012
  • 3
    Barraclough KA, Brown F, Hawley CM, Leary D, Noble E, Campbell SB, Isbel NM, Mudge DW, van Eps CL, Johnson DW: A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial. Nephrol Dial Transplant 27:41464153, 2012
  • 4
    Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V, Gammaro L, Brocco G, Restivo G, Bernich P, Lupo A, Maschio G: The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant 16:14161423, 2001
  • 5
    Van Wyck DB, Roppolo M, Martinez CO, Mazey RM, McMurray S, United States Iron Sucrose Clinical Trials G: A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney Int 68:28462856, 2005
  • 6
    KDOQI. National Kidney Foundation: KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease.[Erratum appears in Am J Kidney Dis. 2006 Sep;48(3):518]. Am J Kidney Dis 47:S11145, 2006
  • 7
    Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group: KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl (2): 279335, 2012
  • 8
    Tessitore N, Girelli D, Campostrini N, Bedogna V, Pietro Solero G, Castagna A, Melilli E, Mantovani W, De Matteis G, Olivieri O, Poli A, Lupo A: Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents. Nephrol Dial Transplant 25:39964002, 2010
  • 9
    Locatelli F, Aljama P, Barany P, Canaud B, Carrera F, Eckardt K-U, Horl WH, Macdougal IC, Macleod A, Wiecek A, Cameron S, European Best Practice Guidelines Working Group: Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 19(Suppl 2):ii147, 2004
  • 10
    Rozen-Zvi B, Gafter-Gvili A, Paul M, Leibovici L, Shpilberg O, Gafter U: Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis. Am J Kidney Dis 52:897906, 2008
  • 11
    Albaramki J, Hodson EM, Craig JC, Webster AC: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev 1:CD007857, 2012
  • 12
    Markowitz GS, Kahn GA, Feingold RE, Coco M, Lynn RI: An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin. Clin Nephrol 48:3440, 1997
  • 13
    Fudin R, Jaichenko J, Shostak A, Bennett M, Gotloib L: Correction of uremic iron deficiency anemia in hemodialyzed patients: a prospective study. Nephron 79:299305, 1998
  • 14
    Macdougall IC, Tucker B, Thompson J, Tomson CR, Baker LR, Raine AE: A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 50:16941699, 1996
  • 15
    Fishbane S, Al-Goreja M, Maesaka JK: Reduced nPCR in patients with gastrointestinal (GI) side effects due to ferrous sulphate. J Am Soc Nephrol 9:248, 1998
  • 16
    Wingard RL, Parker RA, Ismail N, Hakim RM: Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin. Am J Kidney Dis 25:433439, 1995
  • 17
    Lenga I, Lok C, Marticorena R, Hunter J, Dacouris N, Goldstein M: Role of oral iron in the management of long-term hemodialysis patients. Clin J Am Soc Nephrol 2:688693, 2007
  • 18
    Nissenson AR, Berns JS, Sakiewicz P, Ghaddar S, Moore GM, Schleicher RB, Seligman PA: Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients. Am J Kidney Dis 42:325330, 2003